<DOC>
	<DOCNO>NCT00002872</DOCNO>
	<brief_summary>RATIONALE : Some drug bleomycin doxycycline , compound like talc , may help control fluid chest cause cancer . It yet know bleomycin , doxycycline , talc effective treating patient malignant pleural effusion . PURPOSE : Randomized phase III trial compare effectiveness bleomycin , doxycycline , talc treat patient malignant pleural effusion .</brief_summary>
	<brief_title>Bleomycin , Doxycycline , Talc Treating Patients With Malignant Pleural Effusions</brief_title>
	<detailed_description>OBJECTIVES : I . Compare intrapleural bleomycin vs. doxycycline vs. talc treatment malignant pleural effusion respect time recurrence effusion . II . Compare treatment respect necessity treatment recurrent effusion . III . Compare treatment respect extent postinfusion complication , include pain dyspnea . IV . Compare treatment respect duration chest tube soft catheter drainage require following pleurodesis . V. Compare treatment respect duration hospitalization retreatment malignant pleural effusion follow recurrence . VI . Compare treatment respect survival . VII . Compare treatment respect impact procedure pain dyspnea . OUTLINE : This randomized trial . Patients stratify type drainage device participate institution . All patient randomize undergo pleurodesis bleomycin , doxycycline , talc indwell pleural catheter . A second procedure undertaken 72 hour later pleural drainage persistently large . Patients follow monthly survival . PROJECTED ACCRUAL : A total 480 patient enter 48 month .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cytologically confirm unilateral malignant pleural effusion exudative effusion positive biopsy tumor type No chylous effusion Drainage effusion chest tube soft catheter require Lung reexpansion demonstrate chest xray Continuing drainage le 250 mL/24 hour ( equivalent measure 4 hour ) PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Hematopoietic : ( within 2 week prior entry ) WBC great 2,000 Platelets great 50,000 Hepatic : Not specify Renal : ( within 2 week prior entry ) Creatinine le 2.5 mg/dL OR Creatinine clearance great 40 mL/min Other : No pregnant nursing woman Adequate contraception require fertile patient PRIOR CONCURRENT THERAPY : No prior sclerosing agent affected side No prior intrapleural therapy No change systemic therapy least 2 week prior randomization Biologic therapy : Not specify Chemotherapy : No prior systemic bleomycin Systemic chemotherapy allow pleurodesis Endocrine therapy : Hormone therapy allow pleurodesis Radiotherapy : No significant radiotherapy affect hemithorax Irradiation painful bone lesion allow affected side field include significant portion pleura Surgery : See Disease Characteristics No prior thoracoscopic lysis adhesion affect side</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>malignant pleural effusion</keyword>
</DOC>